on-invasive assessment of angiographic culprit lesions in patients after acute myocardial infarction (AMI) remains challenging. 1,2 However, identification of these lesions would improve risk assessment and further management for patients after AMI. 3 In comparative studies with intracoronary ultrasound (ICUS), multidetector row computed tomography (MDCT) provides an accurate identification of coronary plaque crosssectional area, vessel size and coronary remodeling. [4] [5] [6] Furthermore, MDCT density values measured within plaques reflect echogenity and plaque composition. 4 MDCT has a high accuracy for the detection of significant coronary artery disease in patients with stable angina. 7 Furthermore, MDCT has been shown to be safe and accurate in assessing the severity of the infarct-related artery and the number of diseased vessels during the first week after AMI. [8] [9] [10] [11] However, there is scarce published data on plaque texture evaluated by 64-slice MDCT in patients early after AMI. In this prospective study, we focus on MDCT to predict culprit lesions and identify multiple complex lesions in patients early after first AMI.
cation (4 patients) of MDCT images.
Study Protocol
MDCT and conventional coronary angiography (CCAG) were performed in all patients. The study protocol was approved by the Human Research Committee of our hospital. All patients gave informed consent for participation in the study.
MDCT
MDCT was performed within 28.8±31.6 h after the onset of chest pain. One hour before the MDCT scan, metoprolol 100 mg (AstraZeneca, Hertfordshire, England) was given to patients with heart rates from 60 to 75 beats/min, and 150 mg was administered in patients with heart rates over 75 beats/min. A further 100-mg dose was used 30 min after the first dose in 17 patients because the target heart rate was still >70 beats/min. Mean heart rate during scanning was 63.1±9.2 beats/min. MDCT images were obtained using a Toshiba Multi-Slice Aquilion 64 system (Toshiba Medical Systems, Tokyo, Japan). A volume data set was acquired (64×0.5 mm collimation, rotation time 0.35 s, tube voltage 120 kV, tube current 350-600 mA). The baseline scan without contrast injection was done for calcium measurement. Contrast (Iopromide, 350 mg I/ml, 100 ml) was injected at a flow rate of 3.5-4.5 ml/s, and followed by a 50-ml saline bolus chaser with a flow rate of 2.5-3.5 ml/s. Manufacturerprovided bolus tracing program was used to monitor (1.25-s intervals) contrast signal intensity at the ascending aorta. Once signal intensity reached the predefined threshold of 100 Hounsfield units (HU), the patient was automatically instructed to maintain an inspiratory breath hold (around 10 s), during which the CT data and electrocardiographic trace were acquired. 8 Electrocardiogram tube dose modulation was on from 45 to 85% of R-R interval due to the reason that AMI patients were prone to have irregular R-R intervals. The raw data from the scans were reconstructed using medium to sharp kernel, which is optimized for coronary angiography (FC43), and a half scan algorithm was applied for patients with a heart rate <65 beats/min or segmental (2 or 3) reconstruction algorithm for patients with a heart rate >65 beats/min. The image data, acquired during the mid-to-end diastolic phase from the selected reconstructions with least motion artifacts, were transferred to an off-line computer workstation (Vitrea2, Vital Image, MN, USA). These MDCT data were analyzed by 2 experienced independent reviewers blinded to the patients' data.
Definitions of MDCT Assessment
(1) Remodeling index: the cross-sectional area at the site of maximal luminal narrowing divided by the crosssectional area in the reference segment. 5 (2) Luminal area stenosis: the cross-sectional area of reference lumen minus the cross-sectional area of minimal lumen divided by the cross-sectional area of reference lumen cross-sectional area. (3) Plaque plus media cross-sectional area: the cross-sectional area of external arterial wall minus the crosssectional area of lumen. (4) Plaque burden: the plaque plus media cross-sectional area divided by the external arterial wall cross-sectional area.
MDCT Measurement
For the remodeling index and plaque burden analysis, a fixed image display setting (window 700 HU, level 230 HU) was used. The image that displayed maximal luminal narrowing was identified by visual estimation and the external arterial wall (border to low-signal epicardial fat) and coronary luminal contour were manually traced to measure the cross-sectional area. Similarly, the coronary luminal and total cross-sectional area were determined in a reference segment without detectable plaque proximal and as close as possible to the respective coronary lesion. 5 For plaque density analysis, the optimal image display setting was chosen on an individual basis, in general at a window width between 600 and 900 HU and at a level between 150 and 250 HU. 4 We used multiplanar reconstruction technique to obtain 1-mm thick transverse slice of the vessel. For stenotic lesions, 5 regions of interest of 1mm 2 were randomly placed inside the entire plaque area; for occlusive lesions, the size of the region of interest encompassed most of the plaque area. The region of interests were placed away from the lumen, calcification or epicardial fat to avoid partial volume effect. This procedure was repeated in 3 contiguous slices. The average of all the measurements obtained from the 3 contiguous slices was calculated for further analysis. 10 For the calcium score analysis, we used a CT number threshold of 130 HU for identification of a calcified lesion and a minimum area of 1.02 mm 2 as the lower limit to differentiate calcified lesions from noise. The lesion score was calculated by multiplying the lesion area by a density factor derived from the maximal HU within this area, as described by Agatston et al. 12, 13 A total calcium score was determined by adding individual lesion scores from 4 anatomic sites (left main, left anterior descending, left circumflex, and right coronary arteries).
CCAG
All patients received CCAG within 24 h after MDCT. CCAG were analyzed by an independent physician blind to clinical and MDCT data. Coronary artery lesions were identified by quantitative CCAG. Quantitative coronary angiography was used to measure coronary artery lesion dimensions and stenosis with CAAS II system (Pie Medical, Maastricht, The Netherlands). The infarct-related vessel was determined on the coronary artery territory subtended by the regions of acute electrocardiographic changes, wallmotion abnormality and perfusion defect on MDCT. If the culprit vessel had more than 2 lesions, the most severe proximal stenosis or a stenosis identified with thrombus was considered as the culprit lesion. 8 The non-culprit active complex lesions were identified by previous criteria: an intraluminal filling defect consistent with thrombus, defined as abrupt vessel cutoff with persistence of contrast, or an intraluminal filling defect in a patent vessel within or adjacent to a stenotic region with surrounding homogeneous contrast opacification; plaque ulceration, defined by the presence of contrast and hazy contour beyond the vessel lumen; plaque irregularity, defined by irregular margins or overhanging edges; and impaired flow. 14, 15 Other non-culprit lesions were identified as stable non-culprit lesions.
Statistics
Categorical data are presented as absolute values and percentages, whereas continuous variables are summarized as mean values ± standard deviation. Two-tailed Student's t-test was carried out for comparison of continuous data. Chi-square test was used for comparison of categorical data.
Individual regression analysis was used to select potential independent predictors from MDCT indices for discriminating culprit from non-culprit lesions. Covariables examined included residual luminal cross-sectional area, external arterial wall cross-sectional area, luminal artery stenosis, remodeling index, plaque area, plaque burden and lesion density. Individual predictors of culprit lesion selected on the basis of a probability value of <0.05 were entered into a multivariate discriminant analysis. Optimal cutoff values of individual parameters for differentiation between culprit and non-culprit lesions were determined with a receiveroperator characteristic curve. Sensitivity, specificity, predictive accuracy, positive and negative prediction rate were determined and expressed as percentages. A probability value of <0.05 was considered statistically significant. For determination of interobserver variability, mean differences between the measurements of 2 observers were calculated; percentage variability was derived as the absolute difference between the 2 sets of measurements, divided by the mean of the 2 observations.
Results
The baseline demographic, clinical, electrocardiographic, hemodynamic and angiographic data of the 103 patients (91 male, age of 57.1±14.7 years old) are shown in 
Table 3 The MDCT Parameters Used as Dependent Variables for Multivariate Discriminate Analysis of Discrimination Between Culprit Lesions and Non-Culprit Lesions in Patients After First Acute Myocardial Infarction
Abbreviations see in Table 2 . 
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were identified, including: 64 in the left anterior descending, 20 in left circumflex and 47 in the right coronary artery (p=0.119 compared with culprit lesions) ( Table 2) . Comparing infarct-related and non-infarct-related vessels, there was no difference in calcium score measurement. In the lesion luminal measurements, there were statistically significant differences in minimal and maximal lumen diameter, residual lumen cross-sectional area, minimal and maximal external arterial wall diameter and external arterial wall cross-sectional area in the culprit lesions compared with the non-culprit lesions ( Table 2 ). The luminal density did not differ between culprit and non-culprit lesions. The culprit lesions had a significantly higher percentage of lumen artery stenosis (72.6±25.9% vs 60.5±24.0%, p<0.001) and remodeling index (1.3±0.3 vs 1.1±0.3, p=0.024) than the non-culprit lesions (Table 2) .
There was no statistically significant difference in plaque length between culprit and non-culprit lesions (13.5± 7.5 mm vs 11.2±21.6 mm, p=0.351). In the culprit lesions, plaque area and burden were significantly larger than those in the non-culprit lesions (p<0.001, Table 2 ). The MDCT lesion density in the culprit lesions was significantly less than density in the non-culprit lesions (33.2±13.8 vs 76.4± 19.9 HU, p<0.001, Table 2 ) (Fig 1) .
Individual analysis showed that the residual luminal cross-sectional area, external arterial wall cross-sectional area, luminal artery stenosis, remodeling index, plaque area, plaque burden and lesion MDCT density were associated with culprit lesions. These parameters were therefore used as dependent variables for multivariate analysis of discrimination between culprit and non-culprit lesion (Table 3) . MDCT lesion density was the strongest dependent predictor for discrimination of culprit from non-culprit lesion. Receiver-operator characteristic curve analysis identified the optimal cutoff value of lesion density for discrimination between culprit and non-culprit lesion as 49.6 HU; this value was associated with a sensitivity, specificity, accuracy, negative and positive prediction rate of 88.4%, 87.4%, 87.9%, 89.8% and 85.7%, respectively.
In non-culprit lesion, 21 non-culprit active complex lesions were found (Fig 2) . The MDCT density of these non-culprit active complex lesions was significantly higher than that of culprit lesions (48.3±15.7 vs 33.2±13.8 HU, p< 0.001). The MDCT lesion density in the stable non-culprit lesions (81.8±15.5 HU) was significantly higher than that in the culprit lesions or non-culprit active complex lesions (p<0.001, Fig 3) .
Interobserver differences of the measurements of MDCT stenosis was 5.2±3.2%, remodeling index 5.9±3.6%, plaque area 4.9±3.9%, and MDCT density 5.7±3.7%.
Discussion
Patients with recent onset or evolving non-ST elevation AMI remain at risk of suffering recurrent events in the weeks and months following their initial presentation. Although CCAG plus ICUS is the gold standard for characterizing culprit lesions and active complex lesions, it is limited by its invasive nature and cannot be carried out in a routine clinical setting. Therefore, non-invasive methodology could constitute a more attractive alternative, especially in patients with non-ST elevation AMI. We showed using standard ICUS methodology (ie, luminal cross-sectional measurements of stenosis, plaque area) that 64-slice MDCT, with its additional ability to measure lesion density, is useful in assessing culprit and active complex lesions. The MDCT lesion density was found to be an important independent predictor for discrimination between culprit and non-culprit lesions, and able to identify active complex lesions.
Atherosclerotic plaque composition and configuration are important predictors of plaque stability. 16 Vulnerable (rupture-prone) plaques contain a soft, lipid-rich core that is covered by a thin and inflamed cap of fibrous tissue and greater plaque burden than stable plaques which was shown by ICUS study and pathologic lesion. [17] [18] [19] Culprit lesion, caused by ruptured, eroded or spot-calcified plaques and often containing thrombus, is responsible for AMI event. 17 MDCT is a promising tool for assessing luminal crosssectional stenosis, plaque area, burden and soft plaque density. [4] [5] [6] 20, 21 Compared with ICUS, it has limited resolution in precisely depicting the lipid-rich core, fibrous cap, thrombus, or calcified sprinkles. However, neither method can adequately differentiate soft plaque from thrombus. 21, 22 Culprit lesions in patients with acute coronary syndrome (ACS) had significantly greater plaque area and a higher remodeling index than non-culprit lesions. 23 More positive remodeling in the culprit lesions was shown in this study, but remodeling index was not an independent predictor for discrimination between culprit and non-culprit lesions; this is supported by a recent ICUS study, 24 which found that 55% of AMI patients presented expansive remodeling (remodeling index >1.05), and 25% AMI patients presented constrictive remodeling (remodeling index <0.95). In the present study, the culprit lesions had significantly greater plaque burden than non-culprit lesions, and MDCT lesion density was found to be an independent predictor for discrimination of culprit from non-culprit lesions. Kerensky et al reported that an angiographic culprit lesion could not be identified in more than one-third of patients with non-Q-wave AMI if no other modality assisted. 1,2 Therefore, MDCT could provide important information on whether a lesion is culprit or not.
Patients with ACS are associated with pancoronary atherosclerotic plaque destabilization. Kunimasa et al have Fig 3. Comparison of multidetector row computed tomography (MDCT) lesion density between culprit (n=103), non-culprit active complex lesions (n=21) and stable non-culprit lesions (n=108). The MDCT density of these non-culprit active complex lesions was significantly higher than that of culprit lesions (48.3±15.7 vs 33.2± 13.8 Hounsfield units, p<0.001). The MDCT lesion density in the stable non-culprit lesions (81.8±15.5 Hounsfield units) was significantly higher than that in the culprit lesions or nonculprit active complex lesions (p<0.001).
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demonstrated that patients with ACS more frequently had MDCT-low density plaques in the non-culprit, remote arteries than those with non-ACS by per-patient analysis. 25 Previous CCAG studies showed that AMI patients with multiple active complex lesions have a poor clinical prognosis, particularly in terms of higher incidence of recurrent angina and ACS, and were more likely to require repeated angioplasty. 14, 15 Although ICUS or angioscopy can more precisely detect active complex lesion, especially plaques with insignificant lumnal stenosis, the additional clinical significances are still undetermined. [25] [26] [27] [28] In the present study, 64-slice MDCT assessed coronary plaque lesions which were classified by CCAG criteria, and showed there were different characterizations by per-plaque analysis. The results can non-invasively provide the functional relevance of coronary plaques in patients with AMI. Taken together, MDCT might provide information about multiple complex lesions, which could help physicians determine which strategies to adopt to stabilize plaques: pharmacologic intervention or multilesion revascularization.
Study Limitations
Several limitations should be mentioned. First, we did not perform ICUS, which is the gold standard for detecting and characterizing plaques. Although previous studies have shown that MDCT-derived plaque configuration, including MDCT density, remodeling index and plaque burden, had good agreement with ICUS, 4-6 MDCT's spatial resolution (0.5 mm) and lesions with heavy calcification still limit its accuracy for quantification measurement. Future technical developments will enable direct visualization of these anatomical alterations. Second, the small number of patients is a limitation of the current study. In our study, 2 patients with motion artifacts of MDCT images and 4 patients having severe calcification at the culprit lesion/non-culprit lesion segments, interfering with the accuracy of measurement, were excluded. Advanced dual-source MDCT might be more suitable for these patients after AMI. Additionally, our MDCT findings need to be confirmed by histopathologic studies.
Conclusions
This prospective MDCT study found that culprit lesions have significantly lower lesion density and significantly larger residual luminal stenosis, remodeling index, plaque area and burden than non-culprit lesions. MDCT lesion density was able to discriminate culprit from non-culprit lesions. MDCT can predict culprit lesions, and evaluate multiple complex lesions, aiding in risk stratification and management in patients early after AMI.
